Posted in | News | Business | Electronics

Ultracapacitor Manufacturer, Ioxus, Opens Second Plant in Oneonta

Ioxus, a manufacturer of premium performance ultracapacitor technology for use in transportation, industrial and energy applications, today announced the opening of its second manufacturing facility in Oneonta, New York.

The 22,000 sq. ft. plant, located less than a mile from Ioxus’ headquarters, will create increased capacity for both electrode manufacturing and module assembly to meet rapidly increasing demands for Ioxus products worldwide.

Ultracapacitors charge and discharge quickly, making them ideal for voltage support needs and recovering energy that would otherwise be lost. The design of Ioxus ultracapacitors allows for high duty cycle and a sustained high current throughput, which is integral to energy efficiency and achieving the optimum level of energy regeneration.

“Opening our second plant in Oneonta is the culmination of a busy four months for the company. So far in 2014 we announced FlexGen Power and The Long Island Rail Road as new customers, launched the iMOD X-Series™ and received $21 million in series C funding,” said Mark McGough, CEO, Ioxus. “Customers love our products, and that is why we are seeing Ioxus ultracaps designed into a broad array of products including buses, trains, cars, heavy machinery, solar panels and other industrial equipment. The expansion of our manufacturing facilities allows us to meet the supply requirements of major new customers in these applications. Worldwide, Ioxus now utilizes over 100,000 square feet of manufacturing capability in four locations.”

Ioxus’ new site will add more than 30 new jobs in the Oneonta community, increasing the number of US employees to 150.

Additional Ioxus Information:

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.